184 related articles for article (PubMed ID: 17675154)
21. Evidence for expression of early myeloid antigens in mature, non-blast myeloid cells in myelodysplasia.
Xu D; Schultz C; Akker Y; Cannizzaro L; Ramesh KH; Du J; Ratech H
Am J Hematol; 2003 Sep; 74(1):9-16. PubMed ID: 12949884
[TBL] [Abstract][Full Text] [Related]
22. Changes in hemopoietic precursors after treatment of low-risk myelodysplasia with amifostine.
Ribeiro E; Lima CS; Metze K; Souza CA; Lorand-Metze I
In Vivo; 2003; 17(2):181-4. PubMed ID: 12792983
[TBL] [Abstract][Full Text] [Related]
23. [Preliminary study of biological characteristics of myelodysplastic syndromes clonal cells].
Li X; Wu LY; Ying SX; Chang CK; He Q; Song LQ; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):478-83. PubMed ID: 18072633
[TBL] [Abstract][Full Text] [Related]
24. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.
Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW
Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029
[TBL] [Abstract][Full Text] [Related]
25. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes.
Tang G; Wang SA; Menon M; Dresser K; Woda BA; Hao S
Leuk Res; 2011 Jun; 35(6):766-70. PubMed ID: 21367453
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosis.
Pyrovolaki K; Mavroudi I; Sidiropoulos P; Eliopoulos AG; Boumpas DT; Papadaki HA
Arthritis Rheum; 2009 Feb; 60(2):543-52. PubMed ID: 19180486
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome.
Font P; Subirá D; Mtnez-Chamorro C; Castañón S; Arranz E; Ramiro S; Gil-Fernández JJ; López-Pascual J; Alonso A; Pérez-Sáenz MA; Alaez C; Renedo M; Blas C; Escudero A; Fdez-Rañada JM
Leuk Res; 2006 Aug; 30(8):957-63. PubMed ID: 16417922
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotypic features of granulocytes, monocytes, and blasts in myelodysplastic syndromes.
Moon HW; Huh JW; Lee M; Hong KS; Chung WS
Korean J Lab Med; 2010 Apr; 30(2):97-104. PubMed ID: 20445324
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes.
Buccisano F; Maurillo L; Tamburini A; Del Poeta G; Del Principe MI; Ammatuna E; Consalvo MI; Campagna S; Ottaviani L; Sarlo C; Renzi D; Faccia S; Fraboni D; Lo Coco F; Amadori S; Venditti A
Eur J Haematol; 2008 Feb; 80(2):107-14. PubMed ID: 18028430
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
31. BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype.
Kaiser S; Hackanson B; Follo M; Mehlhorn A; Geiger K; Ihorst G; Kapp U
Cytotherapy; 2007; 9(5):439-50. PubMed ID: 17786605
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic analysis of myelodysplastic syndromes.
Del Cañizo MC; Fernández ME; López A; Vidriales B; Villarón E; Arroyo JL; Ortuño F; Orfao A; San Miguel JF
Haematologica; 2003 Apr; 88(4):402-7. PubMed ID: 12681967
[TBL] [Abstract][Full Text] [Related]
33. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
34. Association between phenotypic features of blasts and the blast percentage in bone marrow of patients with myelodysplastic syndromes.
Ogata K; Satoh C; Hyodo H; Tamura H; Dan K; Yoshida Y
Leuk Res; 2004 Nov; 28(11):1171-5. PubMed ID: 15380341
[TBL] [Abstract][Full Text] [Related]
35. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up.
Thiele J; Kvasnicka HM; Zerhusen G; Vardiman J; Diehl V; Luebbert M; Schmitt-Graeff A
Ann Hematol; 2004 Aug; 83(8):513-21. PubMed ID: 15173958
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes.
Satoh C; Dan K; Yamashita T; Jo R; Tamura H; Ogata K
Leuk Res; 2008 May; 32(5):699-707. PubMed ID: 17936901
[TBL] [Abstract][Full Text] [Related]
37. CD34+ hemopoietic precursor and stem cells traffic in peripheral blood of celiac patients is significantly increased but not directly related to epithelial damage severity.
Mastrandrea F; Semeraro FP; Coradduzza G; Manelli M; Scarcia G; Pezzuto F; Serio G
Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):90-103. PubMed ID: 19334373
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of circulating CD34+ cells in myelodysplastic syndromes.
Cesana C; Klersy C; Brando B; Nosari A; Scarpati B; Scampini L; Molteni A; Nador G; Santoleri L; Formenti M; Valentini M; Mazzone A; Morra E; Cairoli R
Leuk Res; 2008 Nov; 32(11):1715-23. PubMed ID: 18456323
[TBL] [Abstract][Full Text] [Related]
40. Significance of CD34(-) and CD34(+) cell apoptosis and proliferation in bone marrow of patients with MDS and their impact on survival.
Xia B; Guo Q; Zhao DD; Zhao HF; Han XP; Wang H; Wu XX; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1392-7. PubMed ID: 23257440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
